Literature DB >> 17128409

Comparative cytokeratin distribution patterns in cholesteatoma epithelium.

E Olszewska1, H Sudhoff.   

Abstract

Cytokeratins (CKs) are known as the intermediate filament proteins of epithelial origin. Their distribution in human epithelia is different according to the type of epithelium, state of growth and differentiation. We used monoclonal mouse antibodies against cytokeratins to study CK expression in the following human tissues: cholesteatoma, middle ear mucosa, glandular epithelium, and meatal ear canal epithelium. Immunohistochemical processing was performed using the labeled steptavidin peroxidase method to demonstrate the presence of CKs in cells of human epidermis. Positive reaction was obtained for CK4, CK34betaE12, CK10, CK14 in skin and cholesteatoma epithelium. However, a more extensive positive reaction with those CKs was observed in cholesteatoma epithelium. Positive immunoreactivity was seen with anti- CK19 in the glandular epithelium. Middle ear mucosa specimens revealed positive immunoreactivity with the antibodies against CK4. The expression of CK4 was definitely positive within the basal layers of the epidermis. The glandular epithelium showed no positive reaction with anti- CK4, anti- CK34betaE12, anti- CK14 and anti-CK10. Immunohistochemistry for CK18 showed no reaction in all examined tissues. Cholesteatoma is known as a proliferative disease in the middle ear which pathogenesis is not completely understood. Keratinocytes express hyperproliferation- associated CKs and after reaching the suprabasal layers they finally undergo apoptosis creating keratinous debris. Cytokeratin expression observed in the epithelium explains proliferative behavior of cholesteatoma which is associated with increased keratinocyte migration. Cytokeratins can be used as potential proliferative markers. It can also allow for searching the usefulness of inhibiting regulators in the treatment of hyperproliferative diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17128409     DOI: 10.14670/HH-22.37

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  9 in total

1.  Pathogenesis of middle ear cholesteatoma: a new model of experimentally induced cholesteatoma in Mongolian gerbils.

Authors:  Tomomi Yamamoto-Fukuda; Yoshitaka Hishikawa; Yasuaki Shibata; Toshimitsu Kobayashi; Haruo Takahashi; Takehiko Koji
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

2.  Laser-assisted cholesteatoma surgery: technical aspects, in vitro implementation and challenge of selective cell destruction.

Authors:  Philipp P Caffier; Ulrike Marzahn; Andrea Franke; Holger Sudhoff; Sergije Jovanovic; Andreas Haisch; Benedikt Sedlmaier
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-06       Impact factor: 2.503

Review 3.  Animal models of middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Haruo Takahashi; Takehiko Koji
Journal:  J Biomed Biotechnol       Date:  2011-04-06

4.  Comparison of changes in mitochondrial bioenergetics between keratinocytes in human external auditory canal skin and cholesteatomas from normoxia to hypoxia.

Authors:  Cheng-Ping Shih; Jen-Tin Lee; Hang-Kang Chen; Yi-Chun Lin; Hsin-Chien Chen; Yuan-Yung Lin; Chao-Yin Kuo; Yu-Ting Chen; Chih-Hung Wang
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

5.  Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma.

Authors:  Enikő Palkó; Szilárd Póliska; István Sziklai; András Penyige
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

Review 6.  Pathogenesis of Retraction Pocket of the Tympanic Membrane-A Narrative Review.

Authors:  Milan Urík; Miroslav Tedla; Pavel Hurník
Journal:  Medicina (Kaunas)       Date:  2021-04-28       Impact factor: 2.430

7.  Identification of novel cholesteatoma-related gene expression signatures using full-genome microarrays.

Authors:  Christin Klenke; Sebastian Janowski; Daniela Borck; Darius Widera; Jörg Ebmeyer; Jörn Kalinowski; Anke Leichtle; Ralf Hofestädt; Tahwinder Upile; Christian Kaltschmidt; Barbara Kaltschmidt; Holger Sudhoff
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

8.  Comparative analysis of the expression of involucrin, filaggrin and cytokeratin 4, 10, 16 in cholesteatoma.

Authors:  Hyun Jung Min; Chul Won Park; Jin Hyeok Jeong; Seok Hyun Cho; Kyung Rae Kim; Seung Hwan Lee
Journal:  Korean J Audiol       Date:  2012-12-18

9.  Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.

Authors:  Anders Britze; Rune Isak Dupont Birkler; Niels Gregersen; Therese Ovesen; Johan Palmfeldt
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.